FOI Request 222 1415
The Drug Utilisation Sub Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) utilisation analysis of testosterone considered at the October 2012 meeting of DUSC.
Page last updated: 27 May 2015
Thank you for taking the time to provide feedback. It will be used to make improvements to this website.